Problem

Moonset Health addresses the documentation burden in hospice and post-acute care, where nurses can spend hours completing notes after visits. That “time tax” contributes to burnout, delays documentation, increases reliance on memory, and pulls clinicians away from patients. The core economic value is recovered clinical capacity: in Moonset’s Horizon Hospice case study, most nurses reported saving one to two hours per day, helping the organization increase census capacity. The clearest use cases are labor-intensive hospice admissions, routine visits, and interdisciplinary-group meetings, where documentation demands are especially high.

Product / Service

Moonset is a B2B cloud-based AI scribe and operational assistant for hospice, home health, and other post-acute teams. A clinician records a visit or IDG meeting on a phone, tablet, or other device; Moonset transcribes the audio, summarizes observations, and produces a structured, HIPAA-compliant note. It supports customizable visit and IDG templates, works as a companion to existing EHRs rather than requiring an EHR replacement, and can read patient data and write charts.

The product goes beyond transcription by checking documentation for quality, regulatory completeness, and potential hospice eligibility or recertification gaps tied to LCD and CMS requirements. Moonset says it can generate clinical-grade notes in five to ten minutes and reduce charting time by as much as 75%; its commercial terms describe annual subscriptions priced by product tier and customer usage. The benefit is faster, more consistent, audit-ready documentation while returning nurses’ time and attention to patient care.

Market

Moonset competes in the vertical healthcare AI-scribe and clinical-workflow-automation market, with a focused position in senior post-acute care: hospice, home health, skilled nursing, and related care-at-home settings. Its competitive set includes purpose-built platforms such as Eleos, Enzo, Lime, and WellSky’s SkySense AI, as well as broader clinical-scribe products such as DeepScribe, Nuance DAX, Suki, Sunoh, and Roger AI. Moonset’s differentiation is its hospice-specific model and workflows, including IDG notes, compliance checks, and eligibility-related documentation rather than generic ambulatory transcription alone.

The company appears to be an early commercial-stage startup rather than pre-revenue. It was founded in 2024, participated in Y Combinator’s Fall 2024 batch, and is listed as active with a team of roughly five to six people. PitchBook reports a $500,000 accelerator financing from Y Combinator and marks the company as generating revenue, although it does not disclose current revenue or customer counts. Moonset has public deployment evidence through its Horizon Hospice case study and an iOS app with six ratings, suggesting initial customer usage but still limited publicly visible scale.